A carregar...
High metallothionein predicts poor survival in glioblastoma multiforme
BACKGROUND: Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor. Even with vigorous surgery, radiation and chemotherapy treatment, survival rates of GBM are very poor and predictive markers for prognosis are currently lacking. METHODS: We performed whole genome expr...
Na minha lista:
| Publicado no: | BMC Med Genomics |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4618994/ https://ncbi.nlm.nih.gov/pubmed/26493598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12920-015-0137-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|